Nucleic Acid Amplification Testing Market Strategic Insights and Forecasts 2034
Global Nucleic Acid Amplification Testing Market Growth, Size, Trends Analysis- By Type, By Application, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Jun-2025 | Report ID: HLCA25168 | Pages: 1 - 250 | Formats*: |
| Category : Healthcare | |||
Global Nucleic Acid Amplification Testing Market Introduction and Overview
According to SPER Market Research, the Global Nucleic Acid Amplification Testing Market is estimated to reach USD 37.78 billion by 2034 with a CAGR 12.46%.
The report includes an in-depth analysis of the Global Nucleic Acid Amplification Testing Market, including market size and trends, product mix, Applications, and supplier analysis. The growing demand for advanced rapid diagnostics, along with increased R&D investments in novel biotechnological testing methods, is driving market growth. Additionally, the high global incidence of infectious diseases and the urgent need for efficient testing solutions to manage outbreaks have significantly boosted the adoption of various nucleic acid amplification testing (NAAT) technologies. The COVID-19 pandemic further accelerated this demand, highlighting the need for rapid and accurate diagnostic methods to detect the SARS-CoV-2 virus. In response, key industry players have introduced innovative products, including tests based on isothermal nucleic acid amplification technology, to address the surge in demand for rapid and point-of-care diagnostics.
By Type:
Based on type, the market is categorized into polymerase chain reaction (PCR) tests, isothermal nucleic acid amplification technology (INAAT) tests, and ligase chain reaction (LCR) tests. Among these, PCR tests currently dominate the market and are projected to experience the most rapid growth in the coming years. This is largely due to the technology’s ability to quickly and accurately detect a wide range of target nucleic acid molecules, including pathogens that are challenging to culture in laboratory conditions. Furthermore, the broad adoption of PCR technology has expanded its use across various applications, such as detecting, quantifying, and genotyping different bacteria and viruses from a variety of clinical samples, including plasma, serum, semen, and cerebrospinal fluid. These advantages are expected to continue driving strong growth in the PCR tests segment.
By Application:
The market is segmented by application into infectious disease testing, oncology testing, genetic and mitochondrial disease testing, and others. Infectious disease testing currently leads the market, driven by the widespread occurrence of illnesses like influenza and sexually transmitted infections. The COVID-19 pandemic further boosted this segment through the introduction of new PCR-based tests, including at-home options. Meanwhile, oncology testing is expected to expand rapidly, supported by growing research efforts and advancements in cancer diagnostics and personalized medicine.
By End Use:
The central and reference laboratories segment generated the highest revenue share in 2022, supported by its comprehensive range of testing services and broad reach across diverse healthcare settings. Government initiatives have also contributed to the growth of these laboratories by helping expand their testing capabilities. For example, the Department of Health and Human Services partnered with several major laboratory companies to increase Monkeypox testing capacity.
Regional Insights:
North America led the market in 2024, driven by the high prevalence of chronic diseases and a well-established healthcare and research infrastructure. The region's growing focus on point-of-care diagnostics and strong disease prevention efforts support the demand for nucleic acid amplification tests. For example, BD and CerTest Biotec developed a PCR assay for monkeypox. Meanwhile, Asia Pacific is projected to experience the fastest growth due to its large population, healthcare advancements, and rising cases of emerging infectious diseases like Japanese encephalitis and Nipah virus.
Market Competitive Landscape:
The global Nucleic Acid Amplification Testing Market is moderately consolidated. Key companies include: F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, Danaher Corporation, Abbott Laboratories, Illumina, Inc., Siemens Healthineers, bioMérieux SA, Novartis AG, Bio-Rad Laboratories, Inc., Seegene Inc.
Recent Developments:
In October 2022, Sherlock Biosciences partnered with Harvard University's Office of Technology Development to secure a global license for a technology that enables the amplification of nucleic acid molecules at room temperature.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Type, By Application, By End Use |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, Danaher Corporation, Abbott Laboratories, Illumina, Inc., Siemens Healthineers, bioMérieux SA, Novartis AG, Bio-Rad Laboratories, Inc., Seegene Inc. |
Key Topics Covered in the Report
- Global Nucleic Acid Amplification Testing Market Size (FY’2021-FY’2034)
- Overview of Global Nucleic Acid Amplification Testing Market
- Segmentation of Global Nucleic Acid Amplification Testing Market By Type {Polymerase Chain Reaction (PCR) Tests, Isothermal Nucleic Acid Amplification Technology (INAAT) Tests, Ligase Chain Reaction (LCR) Tests)
- Segmentation of Global Nucleic Acid Amplification Testing Market By Application (Infectious Disease Testing, Oncology Testing, Genetic & Mitochondrial Disease Testing, Others)
- Segmentation of Global Nucleic Acid Amplification Testing Market By End-use (Hospitals, Central And Reference Laboratories, Others)
- Statistical Snap of Global Nucleic Acid Amplification Testing Market
- Expansion Analysis of Global Nucleic Acid Amplification Testing Market
- Problems and Obstacles in Global Nucleic Acid Amplification Testing Market
- Competitive Landscape in the Global Nucleic Acid Amplification Testing Market
- Details on Current Investment in Global Nucleic Acid Amplification Testing Market
- Competitive Analysis of Global Nucleic Acid Amplification Testing Market
- Prominent Players in the Global Nucleic Acid Amplification Testing Market
- SWOT Analysis of Global Nucleic Acid Amplification Testing Market
- Global Nucleic Acid Amplification Testing Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1.Introduction
1.1.Scope of the report1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data2.1.2.Primary Data2.1.3.SPERs internal database2.1.4.Premium insight from KOLs
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers4.1.2.Restraints4.1.3.Opportunities4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths5.1.2.Weaknesses5.1.3.Opportunities5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape5.2.2.Economic Landscape5.2.3.Social Landscape5.2.4.Technological Landscape
5.2.5.Environmental Landscape5.2.6.Legal Landscape
5.3.PORTERs Five Forces
5.3.1.Bargaining power of suppliers5.3.2.Bargaining power of buyers5.3.3.Threat of Substitute
5.3.4.Threat of new entrant5.3.5.Competitive rivalry
5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Global Nucleic Acid Amplification Testing Market Manufacturing Base Distribution, Sales Area, Product Type6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Nucleic Acid Amplification Testing Market
7.Global Nucleic Acid Amplification Testing Market, By Type, (USD Million) 2021-2034
7.1.Polymerase Chain Reaction (PCR) Tests7.2.Isothermal Nucleic Acid Amplification Technology (INAAT) Tests7.3.Ligase Chain Reaction (LCR) Tests
8.Global Nucleic Acid Amplification Testing Market, By Application, (USD Million) 2021-2034
8.1.Infectious Disease Testing
8.1.1.COVID-19 Testing8.1.2.Mosquito Borne Disease Testing8.1.3.Influenza Testing8.1.4.Sexually Transmitted Infections Testing8.1.5.Hepatitis Testing8.1.6.Tuberculosis Testing8.1.7.Others
8.2.Oncology Testing8.3.Genetic & Mitochondrial Disease Testing8.4.Others
9.Global Nucleic Acid Amplification Testing Market, By End-use, (USD Million) 2021-2034
9.1.Hospitals9.2.Central And Reference Laboratories9.3.Others
10.Global Nucleic Acid Amplification Testing Market, (USD Million) 2021-2034
10.1.Global Nucleic Acid Amplification Testing Market Size and Market Share
11.Global Nucleic Acid Amplification Testing Market, By Region, 2021-2034 (USD Million)
11.1.Asia-Pacific
11.1.1.Australia11.1.2.China11.1.3.India11.1.4.Japan11.1.5.South Korea11.1.6.Rest of Asia-Pacific
11.2.Europe
11.2.1.France11.2.2.Germany11.2.3.Italy11.2.4.Spain11.2.5.United Kingdom11.2.6.Rest of Europe
11.3.Middle East and Africa
11.3.1.Kingdom of Saudi Arabia11.3.2.United Arab Emirates11.3.3.Qatar11.3.4.South Africa11.3.5.Egypt11.3.6.Morocco11.3.7.Nigeria11.3.8.Rest of Middle-East and Africa
11.4.North America
11.4.1.Canada11.4.2.Mexico11.4.3.United States
11.5.Latin America
11.5.1.Argentina11.5.2.Brazil11.5.3.Rest of Latin America
12.Company Profile
12.1.F. Hoffmann-La Roche Ltd
12.1.1.Company details12.1.2.Financial outlook12.1.3.Product summary12.1.4.Recent developments
12.2.Becton, Dickinson and Company
12.2.1.Company details12.2.2.Financial outlook12.2.3.Product summary12.2.4.Recent developments
12.3.Danaher Corporation
12.3.1.Company details12.3.2.Financial outlook12.3.3.Product summary12.3.4.Recent developments
12.4.Abbott Laboratories
12.4.1.Company details12.4.2.Financial outlook12.4.3.Product summary12.4.4.Recent developments
12.5.Illumina, Inc
12.5.1.Company details12.5.2.Financial outlook12.5.3.Product summary12.5.4.Recent developments
12.6.Siemens Healthineers
12.6.1.Company details12.6.2.Financial outlook12.6.3.Product summary12.6.4.Recent developments
12.7.bioMérieux SA
12.7.1.Company details12.7.2.Financial outlook12.7.3.Product summary12.7.4.Recent developments
12.8.Novartis AG
12.8.1.Company details12.8.2.Financial outlook12.8.3.Product summary12.8.4.Recent developments
12.9.Bio-Rad Laboratories, Inc.
12.9.1.Company details12.9.2.Financial outlook12.9.3.Product summary12.9.4.Recent developments
12.10.Seegene Inc.
12.10.1.Company details12.10.2.Financial outlook12.10.3.Product summary12.10.4.Recent developments
12.11.Others
13.Conclusion
14.List of Abbreviations
15.Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Nucleic Acid Amplification Testing Market is projected to reach USD 37.78 billion by 2034, growing at a CAGR of of 12.46% during the forecast period.
Nucleic Acid Amplification Testing Market grew in Market size from 2025. The Market is expected to reach USD 37.78 billion by 2034, at a CAGR of 12.46% during the forecast period.
Nucleic Acid Amplification Testing Market CAGR of 12.46% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Nucleic Acid Amplification Testing Market size is USD 37.78 billion from 2025 to 2034.
Nucleic Acid Amplification Testing Market is covered By Type, By Application, By End Use
The North America is anticipated to have the highest Market share in the Nucleic Acid Amplification Testing Market.
F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, Danaher Corporation, Abbott Laboratories, Illumina, Inc., Siemens Healthineers, bioMérieux SA, Novartis AG, Bio-Rad Laboratories, Inc., Seegene Inc.
The report includes an in-depth analysis of the Global Nucleic Acid Amplification Testing Market, including market size and trends, product mix, Applications, and supplier analysis.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
